2nd Example of .0001 Ask Stock Running - August 26. In

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
2nd Example of .0001 Ask Stock Running - August 26.

In less than 15 minutes today went from .0001 ask to .0003 on 428M volume at that point (only the 32M was from earlier in the day).

Specialists at this end of the market like myself saw a page full of scanner hits as the huge orders went through seconds apart.

Instant 250M+ bid at .0001 on uptick to .0002.

0002 ask not stacked by moronic 1-tick flippers nor .0003 where there was 69M by the time I looked (and at the close).

That's what happens when just a few people are buying 20M/60M/80M at a time and are competing for the last 100M at .0001 and don't get filled.

An instant bid is created by the buy orders that were not filled prior to uptick - - hence why it is important (if you are a big player in the OTC market) to set a buy order for .0002 when trying to buy the last 50M>100M of the .0001s on an uptick otherwise you risk getting left without shares.

The bid quickly increased to 283M .0001 x 69M .0003.

Very few people flipped for 1-tick (or 2). and at the close 506M had been traded and it was 62M .0002 x 64M .0003.

This sort of things happens all the time at the very bottom of the OTC sector - now on average once per week over the last month.

Clearly the people posting on the iHub REDG board are not experienced full-time traders in the .0001>.0050 range or they wouldn't state the type of nonsense they do.

Only a matter of time until it is REDG's turn - whether it's on company updates or by the people who have loaded it..

Worth watching at all times now considering the loading since July 1 (see daily update sticky).

Red Giant Entertainment Inc. (REDG) Stock Research Links

REDG Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading